Masataka Yoshida, entering his third season with the Boston Red Sox, faces uncertainty as he continues his recovery from shoulder surgery. Despite being signed to a lucrative five-year, $90 million contract, Yoshida's absence has made him an overlooked figure amidst a 17-15 team start. The Red Sox, having shifted their roster by signing Alex Bregman, have limited available at-bats in the DH spot previously occupied by Yoshida.

While Yoshida showcases hitting potential with a .286 average and a home run during spring training, his throwing ability remains compromised, necessitating further medical evaluation. The team desires him fully fit for outfield play, a position he must reclaim for a viable role. Meanwhile, trade prospects have dimmed due to lingering health concerns and financial commitments. The Red Sox publicly maintain faith in Yoshida's capabilities, emphasizing his professional hitting skills and potential impact on the game.